Osaic Holdings’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
Other funds holding OTLK
Osaic Holdings's OTLK Position: Q3 2026 in Review
Osaic Holdings reduced its Outlook Therapeutics (OTLK) stake by 21% in Q3 2026, selling an estimated $2.29K and leaving 9,063 shares worth $5.71K. The position accounts for ﹤0.01% of the portfolio, ranked #6898.
Osaic Holdings first reported a position in OTLK in Q1 2020 and has held it in 26 quarters since. The position peaked at $158K in Q2 2021. 82 funds tracked by Wall St. Rank hold OTLK as of Q3 2026.
- Osaic Holdings held 9,063 shares of Outlook Therapeutics worth $5.71K as of Q3 2026.
- Osaic Holdings sold 2,403 Outlook Therapeutics shares in Q3 2026, an estimated $2.29K.
- Outlook Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #6898 holding.
- Osaic Holdings first reported a position in Outlook Therapeutics in Q1 2020 and has held it in 26 quarters since.
- Osaic Holdings's Outlook Therapeutics position peaked at $158K in Q2 2021.
- 82 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.